Ginkgo bioworks stock prediction.
About the Ginkgo Bioworks Holdings, Inc. stock forecast. As of 2023 December 01, Friday current price of DNA-WT stock is 0.0898$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Ginkgo Bioworks Holdings stock price has been showing a declining tendency so we believe that similar market …
Dec 1, 2023 · Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price. View analysts price targets for DNA or view top-rated stocks among Wall Street analysts. 3.90. Nikko Asset Management Americas, Inc. 3.67. ARK Genomic Revolution ETF. 3.25. The latest Ginkgo Bioworks Holdings stock prices, stock quotes, news, and DNA history to help you invest and ...1 DNA stock price increased by 6.86% over the past day and the current price is below all major EMA’s. 2 Ginkgo Bioworks Holdings Inc. ( NYSE: DNA) stock’s 52-week price range is around $1.12 – $2.55. Ginkgo Bioworks Holdings Inc. reported Q2 revenue is down 44% Y-o-Y, mainly due to a fall in Biosecurity revenue.Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for DNA stock stock is $1.88, which predicts an increase of 45.74%. The lowest target is $1.25 and the highest is $2.50. On average, analysts rate DNA stock stock as a sell.Key Insights. Significantly high institutional ownership implies Ginkgo Bioworks Holdings' stock price is sensitive to their trading actions. A total of 7 investors have a majority stake in the ...Ginkgo Bioworks (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, and Google Cloud today announced a five-year strategic cloud and AI partnership ...
Oct 11, 2022. Listen to this article 2 min. Merck & Co. Inc. is hiring synthetic biology firm Ginkgo Bioworks Holdings Inc. to engineer a crucial component of some of its medicines. Through the ...Jul 19, 2023 · How This Affects DNA Stock. Ginkgo Bioworks securing an $18 million contract over a four-year period is exciting investors. It shows the company’s research is valued by a government agency ...
Is Ginkgo Bioworks a stock worth buying? When the stock began trading in September 2021, its valuation was around $15 billion. Today, it has a market capitalization of just $3.2 billion.Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results. $478 million of total revenue in 2022, representing an increase of 52% over 2021 and toward the high end of guidance ...Ginkgo Bioworks, the synthetic ... The $364 million number represents the price of Ginkgo's stock on November 17, 2021, when shares were trading at $13.59 apiece and the value exceeded $20 billionThe 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 1.25.
Ginkgo Bioworks Completes Acquisition of Zymergen ... Zymergen stockholders received, for each share of Zymergen common stock, 0.9179 shares of Ginkgo Class A common stock. Zymergen shares will no longer be traded on Nasdaq. ... These forward-looking statements are only predictions and involve known and unknown …
May 10, 2023 · First quarter 2023 Total revenue of $81 million, down from $168 million in the comparable prior year period, a decrease of 52% driven by the expected ramp down of K-12 testing in Ginkgo's ...
Price target ... Based on analysts projections #DNA is expected to experience a positive growth trajectory over the next year. The current average DNA price ...In about an hour following the publication of Scorpion’s 175-page report, Ginkgo’s stock price dropped at least 20%, down to about $9.50 a share.Nov 21, 2023 · Ginkgo Bioworks Holdings Inc’s trailing 12-month revenue is $315.0 million with a -272.3% profit margin. Year-over-year quarterly sales growth most recently was -16.6%. Analysts expect adjusted earnings to reach $-0.442 per share for the current fiscal year. Buy DNA Stock. See DNA stock price and Buy/Sell Ginkgo Bioworks Holdings. Discuss news and analysts' price predictions with the investor community. Start ...See Ginkgo Bioworks Holdings, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.Ginkgo Bioworks Reports Second Quarter 2022 Financial Results. $145 million of Total revenue in Q2 2022, representing 231% growth over Q2 2021. 13 new Cell Programs added in Q2 2022, representing ...
No opinion on gingko's business model itself, but the fact that some so called "activist" short seller (get fucking real, they're trying to profit off this shit) can basically just re-iterate the companies prospectus and known practices but in the fashion of a teenager trying to dunk on someone on reddit and cause the stock to drop like 20% intraday is genuinely …Forward momentum convinced Wood to buy more than 3 million shares of Archer Aviation stock last week. Now, Ark Invest's stake in the up-and-coming air taxi provider is more than 3 times the size ...Sep. 27, 2023, 07:01 AM. BOSTON, Sept. 27, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug ...Feb 17, 2023 · Last year was not a good one for Ginkgo Bioworks’ stock price, which dropped 80%. Ginkgo’s business model is that it wants to be the Apple (NASDAQ:AAPL) App Store of biotech, the one-stop-shop ... See Ginkgo Bioworks Holdings, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. Find Salaries by Job Title at Ginkgo BioWorks. 25 Salaries (for 18 job titles) • Updated Oct 29, 2023. How much do Ginkgo BioWorks employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips.
Days after trading under its new ticker after completing its SPAC merger with Soaring Eagle Acquisition, Ginkgo Bioworks (NYSE:DNA) is rising higher today, having climbed 5.8% at 11:12 a.m. EDT ...
Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and ...BOSTON, Jan. 12, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today preliminary performance updates for the year ended December ...Ginkgo Bioworks Holdings Inc. analyst ratings, historical stock prices, earnings estimates & actuals. DNA updated stock price target summary.Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, ... million (inclusive of stock-based compensation expense of $111 million), compared to Loss from ... Forward-looking statements are predictions, ...Jan 12 Consensus forecasts updated Dec 20 Show all updates Earnings and Revenue Growth Forecasts Show more Analyst Future Growth Forecasts Earnings …Aug 16, 2022 · What happened. Cutting-edge biotech company Ginkgo Bioworks Holdings ( DNA -4.79%) was a popular stock on Tuesday. The cell engineering specialist's share price zoomed more than 7% higher today ... Ginkgo Bioworks (DNA 8.53%) is a biotech unlike any other, and it's no surprise why it's consistently attracting the attention of bigwig portfolio managers like Cathie Wood.Earnings for Ginkgo Bioworks are expected to grow in the coming year, from ($0.37) to ($0.30) per share. Ginkgo Bioworks has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off prior year's report dates. Read More.
Get the detailed quarterly/annual income statement for Ginkgo Bioworks Holdings, Inc. (DNA). Find out the revenue, expenses and profit or loss over the last fiscal year.
While Ginkgo Bioworks is an exciting company, the pricing of the SPAC stock leaves a lot of room for things to go wrong between now and the company's long …
Ginkgo Bioworks Holdings Inc. research and ratings by Barron's. View DNA revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.Ginkgo BioWorks has an overall rating of 4.0 out of 5, based on over 118 reviews left anonymously by employees. 71% of employees would recommend working at Ginkgo BioWorks to a friend and 61% have a positive outlook for the business. This rating has decreased by -8% over the last 12 months.Fundamentally, Ginkgo Bioworks is a mixed bag with $478 million in 2022 revenues, up 52%, but $2.1 billion in net losses also. Still, at just over $1 per share, DNA stock is poised to more than ...BOSTON and BASEL, Switzerland, March 14, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the entry into a definitive ...Earnings for Ginkgo Bioworks are expected to grow in the coming year, from ($0.37) to ($0.30) per share. Ginkgo Bioworks has not formally confirmed its next …One of the best-performing stocks in today’s market is biotech company Ginkgo Bioworks (NYSE:DNA).Shares of DNA stock rocketed more than 20% higher in early afternoon trading.May 10, 2023 · First quarter 2023 Total revenue of $81 million, down from $168 million in the comparable prior year period, a decrease of 52% driven by the expected ramp down of K-12 testing in Ginkgo's ... By John Blankenhorn, InvestorPlace Contributor Oct 7, 2023, 9:00 am EST. These biotech companies have invested in trials and tech to create a perfect launch for a breakout year. Gingko Bioworks ...
All information and data on the website are for reference only and no historical data shall be considered as the basis for predicting future trends. Information ...Ginkgo Bioworks looks cheaper now than it has at pretty much any other time as a public company. That being said, a P/S over 5 with declining revenue and increasing operating losses isn't exactly ...First quarter 2023 Total revenue of $81 million, down from $168 million in the comparable prior year period, a decrease of 52% driven by the expected ramp down of K-12 testing in Ginkgo's ...Instagram:https://instagram. uber stock predictionswebull minimum deposit for free stockstock tracking websiteswhen does iphone 15 pre order come out Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. ... Ginkgo Bioworks Holdings Inc (NYSE:DNA) Real-Time Quotes. 1.37. While Ginkgo Bioworks is an exciting company, the pricing of the SPAC stock leaves a lot of room for things to go wrong between now and the company's long-term projections. dividend investment calculatorgoldman sachs analyst As a member of the SPAC class of 2021, Ginkgo Bioworks ( NYSE: DNA) stock has seen its fair share of pummeling over the last few years. From an all-time high at ~$16 to the stock's current price ...All information and data on the website are for reference only and no historical data shall be considered as the basis for predicting future trends. Information ... best uk stock brokers Ginkgo Bioworks (NYSE: DNA) sells something very original: the large-scale design and production of organisms. And thanks to its innovations, the company has increased revenue almost 800% over the ...Tesla’s stock is predicted to increase in value in 2015, according to Forbes. In January 2015, Forbes noted that Tesla Motors, Inc.